chr4-138179342-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014331.4(SLC7A11):c.1319C>T(p.Ala440Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,612,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014331.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC7A11 | NM_014331.4 | c.1319C>T | p.Ala440Val | missense_variant | 11/12 | ENST00000280612.9 | NP_055146.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC7A11 | ENST00000280612.9 | c.1319C>T | p.Ala440Val | missense_variant | 11/12 | 1 | NM_014331.4 | ENSP00000280612 | P1 | |
SLC7A11 | ENST00000509248.1 | c.*270C>T | 3_prime_UTR_variant, NMD_transcript_variant | 6/7 | 5 | ENSP00000424046 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152080Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000603 AC: 15AN: 248942Hom.: 0 AF XY: 0.0000593 AC XY: 8AN XY: 134848
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1460442Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 726520
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152198Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74414
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 17, 2023 | The c.1319C>T (p.A440V) alteration is located in exon 11 (coding exon 11) of the SLC7A11 gene. This alteration results from a C to T substitution at nucleotide position 1319, causing the alanine (A) at amino acid position 440 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at